Overall survival benefit in advanced non-small-cell lung cancer

被引：0
|
作者：
Owen, Olwen Glynn
机构：
来源：
BRITISH JOURNAL OF HOSPITAL MEDICINE | 2008年 / 69卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：379 / 379
页数：1
相关论文
共 50 条
  • [1] Chemotherapy and Survival Benefit in Elderly Patients With Advanced Non-Small-Cell Lung Cancer
    Davidoff, Amy J.
    Tang, Mei
    Seal, Brian
    Edelman, Martin J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (13) : 2191 - 2197
  • [2] Functional resilience and overall survival in adults treated for advanced non-small-cell lung cancer
    Presley, Carolyn J.
    Tang, Joy
    Benedict, Jason
    Grogan, Madison
    Reisinger, Sarah
    Janse, Sarah
    Wong, Melisa L.
    Arrato, Nicole A.
    Davenport, Ashley
    Shields, Peter G.
    Andersen, Barbara L.
    [J]. LUNG CANCER, 2024, 196
  • [3] Evaluating the Impact of Bevacizumab Maintenance Therapy on Overall Survival in Advanced Non-Small-Cell Lung Cancer
    Dranitsaris, George
    Beegle, Nancy
    Ravelo, Arliene
    Kalberer, Traci
    Yu, Elaine
    Thomas, Sachdev
    [J]. CLINICAL LUNG CANCER, 2013, 14 (02) : 120 - 127
  • [4] Time trends in overall survival (OS) gain in advanced non-small-cell lung cancer (NSCLC).
    Saad, Everardo D.
    Buyse, Marc E.
    Jassem, Jacek
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [5] Impact of prophylactic Cranial Irradiation on Overall Survival of Patients with advanced non-small-cell Lung Cancer
    Schmidt, Julia
    Appold, Steffen
    Troost, Esther G. C.
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2019, 195 (05) : 453 - 455
  • [6] Modeling Tumor Dynamics and Overall Survival in Advanced Non-Small-Cell Lung Cancer Treated with Erlotinib
    Suleiman, Ahmed Abbas
    Frechen, Sebastian
    Scheffler, Matthias
    Zander, Thomas
    Kahraman, Deniz
    Kobe, Carsten
    Wolf, JRgen
    Nogova, Lucia
    Fuhr, Uwe
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (01) : 84 - 92
  • [7] Overall survival should be the primary endpoint in clinical trials for advanced non-small-cell lung cancer
    Cheema, P. K.
    Burkes, R. L.
    [J]. CURRENT ONCOLOGY, 2013, 20 (02) : E150 - E160
  • [8] Significant survival benefit to patients with advanced non-small-cell lung cancer from treatment with clarithromycin
    Mikasa, K
    Sawaki, M
    Kita, E
    Hamada, K
    Teramoto, S
    Sakamoto, M
    Maeda, K
    Konishi, M
    Narita, N
    [J]. CHEMOTHERAPY, 1997, 43 (04) : 288 - 296
  • [9] Breaking the Glass Ceiling of Overall Survival in Non-Small-Cell Lung Cancer
    Reinmuth, Niels
    Reck, Martin
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (17) : 1647 - +
  • [10] Advanced non-small-cell lung cancer: Benefit of chemotherapy in symptom control
    Margery, J
    Le Moulec, S
    Grassin, F
    Bauduceau, O
    Dot, JM
    Vedrine, L
    Natali, F
    Guigay, JL
    [J]. BULLETIN DU CANCER, 2003, 90 (10) : 917 - 918
12345